Search Results - "Obermann‐Borst, Sylvia A."

The devil is in the details—Using empowering language for parents in the neonatal intensive care unit by Veenendaal, Nicole R., Obermann‐Borst, Sylvia A., Kempen, Anne A. M. W., Labrie, Nanon H. M.

Get full text

‘Not a goal, but a given’: Neonatal care participation through parents' perspective, a cross‐sectional study by Hoeben, Hannah, Obermann‐Borst, Sylvia A., Stelwagen, Mireille A., Kempen, Anne A. M. W., Goudoever, Johannes B., Schoor, Sophie R. D., Veenendaal, Nicole R.

“…Aim To explore parents' perspectives regarding participation in neonatal care, with focus on the family integrated care (FICare) model utilised as a tool to…”
Get full text

Congenital heart defects and biomarkers of methylation in children: a case-control study by Obermann-Borst, Sylvia A., van Driel, Lydi M. J. W., Helbing, Willem A., de Jonge, Robert, Wildhagen, Mark F., Steegers, Eric A. P., Steegers-Theunissen, Régine P. M.

“…Eur J Clin Invest 2011; 41 (2): 143–150 Background  Derangements in the maternal methylation pathway, expressed by global hypomethylation and…”
Get full text

Study protocol for two randomised controlled trials evaluating the effects of Cerclage in the reduction of extreme preterm birth and perinatal mortality in twin pregnancies with a short cervix or dilatation: the TWIN Cerclage studies by van Gils, Lissa, de Boer, Marjon A, Bosmans, Judith, Duijnhoven, Ruben, Schoenmakers, Sam, Derks, Jan B, Prins, Jelmer R, Al-Nasiry, Salwan, Lutke Holzik, Margo, Lopriore, Enrico, van Drongelen, Joris, Knol, Marieke H, van Laar, Judith O E H, Jacquemyn, Yves, van Holsbeke, Caroline, Dehaene, Isabelle, Lewi, Liesbeth, van der Merwe, Hannes, Gyselaers, Wilfried, Obermann-Borst, Sylvia A, Holthuis, Mayella, Mol, Ben W, Pajkrt, Eva, Oudijk, Martijn A

“…IntroductionTwin pregnancies have a high risk of extreme preterm birth (PTB) at less than 28 weeks of gestation, which is associated with increased risk of…”
Get full text

Mind the gap: Comparing parents' information needs about impending preterm birth to current clinical practices using a mixed methods approach by van Zijl, Angela C.M., Obermann-Borst, Sylvia A., Hogeveen, Marije, Verweij, E.J.T. Joanne, de Vries, Willem B., Geurtzen, Rosa, Labrie, Nanon H.M.

“…To identify parents' information needs about impending very preterm birth and compare these needs to current information practices in the Netherlands. Step 1:…”
Get full text

Opportunities and Challenges of Prognostic Models for Extremely Preterm Infants by de Boer, Angret, van Beek, Pauline E, Andriessen, Peter, Groenendaal, Floris, Hogeveen, Marije, Meijer, Julia S, Obermann-Borst, Sylvia A, Onland, Wes, Scheepers, Liesbeth (H. C. J.), Vermeulen, Marijn J, Verweij, E. J. T. (Joanne), De Proost, Lien, Geurtzen, Rosa

“…Predicting the short- and long-term outcomes of extremely preterm infants remains a challenge. Multivariable prognostic models might be valuable tools for…”
Get full text

General maternal medication use, folic acid, the MDR1 C3435T polymorphism, and the risk of a child with a congenital heart defect by Obermann-Borst, Sylvia A., MSc, Isaacs, Aaron, PhD, Younes, Zobia, MD, van Schaik, Ron H.N., PhD, van der Heiden, Ilse P., BSc, van Duyn, Cornelia M., PhD, Steegers, Eric A.P., PhD, Steegers-Theunissen, Régine P.M., PhD

“…Objective We sought to investigate maternal and child functional MDR1 C3435T polymorphism, periconception medication, folic acid use, and the risk of a…”
Get full text

Duration of breastfeeding and gender are associated with methylation of the LEPTIN gene in very young children by Obermann-Borst, Sylvia A., Eilers, Paul H.C., Tobi, Elmar W., de Jong, Frank H., Slagboom, P. Eline, Heijmans, Bastiaan T., Steegers-Theunissen, Régine P.M.

“…Background: Perinatal environmental factors have been associated with the metabolic programming of children and consequent disease risks in later life…”
Get full text

Periconceptional Maternal Folic Acid Use of 400 µg per Day Is Related to Increased Methylation of the IGF2 Gene in the Very Young Child by Steegers-Theunissen, Régine P, Obermann-Borst, Sylvia A, Kremer, Dennis, Lindemans, Jan, Siebel, Cissy, Steegers, Eric A, Slagboom, P. Eline, Heijmans, Bastiaan T

“…Background: Countries worldwide recommend women planning pregnancy to use daily 400 µg of synthetic folic acid in the periconceptional period to prevent birth…”
Get full text

Congenital heart defects and parental occupational exposure to chemicals by Snijder, Claudia A., Vlot, Ingrid J., Burdorf, Alex, Obermann-Borst, Sylvia A., Helbing, Willem A., Wildhagen, Mark F., Steegers, Eric A.P., Steegers-Theunissen, Régine P.M.

“…BACKGROUND Congenital heart defects (CHDs) are the most common major malformations in newborns. In this study we examined the associations between the…”
Get full text

Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child by Steegers-Theunissen, Régine P, Obermann-Borst, Sylvia A, Kremer, Dennis, Lindemans, Jan, Siebel, Cissy, Steegers, Eric A, Slagboom, P Eline, Heijmans, Bastiaan T

“…Countries worldwide recommend women planning pregnancy to use daily 400 microg of synthetic folic acid in the periconceptional period to prevent birth defects…”
Get full text

Periconceptional Maternal Folic Acid Use of 400 [micro]g per Day Is Related to Increased Methylation of the IGF2 Gene in the Very Young Child by Steegers-Theunissen, Régine P, Obermann-Borst, Sylvia A, Kremer, Dennis, Lindemans, Jan, Siebel, Cissy, Steegers, Eric A, Slagboom, P. Eline, Heijmans, Bastiaan T

“…Background Countries worldwide recommend women planning pregnancy to use daily 400 [micro]g of synthetic folic acid in the periconceptional period to prevent…”
Get full text

Congenital heart defects and biomarkers of methylation in children: a case-control study: CONGENITAL HEART DEFECTS AND BIOMARKERS OF METHYLATION by Obermann-Borst, Sylvia A., van Driel, Lydi M. J. W., Helbing, Willem A., de Jonge, Robert, Wildhagen, Mark F., Steegers, Eric A. P., Steegers-Theunissen, Régine P. M.

Get full text

Periconceptional Maternal Folic Acid Use of 400 Amg per Day Is Related to Increased Methylation of the IGF2 Gene in the Very Young Child by Steegers-Theunissen, RACOgine P, Obermann-Borst, Sylvia A, Kremer, Dennis, Lindemans, Jan, Siebel, Cissy, Steegers, Eric A, Slagboom, PEline, Heijmans, Bastiaan T, Zhang, Cuilin

“…Background Countries worldwide recommend women planning pregnancy to use daily 400 Amg of synthetic folic acid in the periconceptional period to prevent birth…”
Get full text